Bartlett & Co’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,863
| Closed | -$90K | – | 1195 |
|
|
2022
Q3 | $90K | Hold |
2,863
| – | – | ﹤0.01% | 471 |
|
|
2022
Q2 | $87K | Sell |
2,863
-1,826
| -39% | -$49.4K | ﹤0.01% | 483 |
|
|
2022
Q1 | $122K | Buy |
+4,689
| New | +$112K | ﹤0.01% | 453 |
|
|
2021
Q4 | – | Sell |
-4,689
| Closed | -$90K | – | 937 |
|
|
2021
Q3 | $90K | Sell |
4,689
-150
| -3% | -$2.99K | ﹤0.01% | 430 |
|
|
2021
Q2 | $107K | Hold |
4,839
| – | – | ﹤0.01% | 401 |
|
|
2021
Q1 | $127K | Sell |
4,839
-300
| -6% | -$7.13K | ﹤0.01% | 382 |
|
|
2020
Q4 | $96K | Hold |
5,139
| – | – | ﹤0.01% | 418 |
|
|
2020
Q3 | $87K | Buy |
5,139
+300
| +6% | +$5.83K | ﹤0.01% | 402 |
|
|
2020
Q2 | $113K | Hold |
4,839
| – | – | ﹤0.01% | 367 |
|
|
2020
Q1 | $41K | Buy |
+4,839
| New | +$40.7K | ﹤0.01% | 501 |
|
|
2019
Q3 | $46K | Hold |
4,839
| – | – | ﹤0.01% | 547 |
|
|
2019
Q2 | $57K | Hold |
4,839
| – | – | ﹤0.01% | 415 |
|
|
2019
Q1 | $85K | Hold |
4,839
| – | – | ﹤0.01% | 340 |
|
|
2018
Q4 | $84K | Hold |
4,839
| – | – | ﹤0.01% | 328 |
|
|
2018
Q3 | $72K | Hold |
4,839
| – | – | ﹤0.01% | 380 |
|
|
2018
Q2 | $77K | Hold |
4,839
| – | – | ﹤0.01% | 360 |
|
|
2018
Q1 | $69K | Hold |
4,839
| – | – | ﹤0.01% | 389 |
|
|
2017
Q4 | $68K | Sell |
4,839
-900
| -16% | -$13.2K | ﹤0.01% | 392 |
|
|
2017
Q3 | $82K | Hold |
5,739
| – | – | ﹤0.01% | 352 |
|
|
2017
Q2 | $90K | Hold |
5,739
| – | – | ﹤0.01% | 332 |
|
|
2017
Q1 | $79K | Hold |
5,739
| – | – | ﹤0.01% | 351 |
|
|
2016
Q4 | $102K | Hold |
5,739
| – | – | ﹤0.01% | 317 |
|
|
2016
Q3 | $111K | Hold |
5,739
| – | – | 0.01% | 306 |
|
|
2016
Q2 | $112K | Buy |
5,739
+900
| +19% | +$17.6K | 0.01% | 305 |
|
|
2016
Q1 | $100K | Sell |
4,839
-2,000
| -29% | -$39.4K | 0.01% | 306 |
|
|
2015
Q4 | $140K | Hold |
6,839
| – | – | 0.01% | 285 |
|
|
2015
Q3 | $117K | Sell |
6,839
-2,050
| -23% | -$37.5K | 0.01% | 297 |
|
|
2015
Q2 | $166K | Hold |
8,889
| – | – | 0.01% | 277 |
|
|
2015
Q1 | $170K | Hold |
8,889
| – | – | 0.01% | 275 |
|
|
2014
Q4 | $146K | Hold |
8,889
| – | – | 0.01% | 285 |
|
|
2014
Q3 | $157K | Buy |
8,889
+150
| +2% | +$2.95K | 0.01% | 272 |
|
|
2014
Q2 | $180K | Hold |
8,739
| – | – | 0.01% | 259 |
|
|
2014
Q1 | $190K | Hold |
8,739
| – | – | 0.01% | 261 |
|
|
2013
Q4 | $232K | Sell |
8,739
-450
| -5% | -$11.1K | 0.01% | 244 |
|
|
2013
Q3 | $217K | Hold |
9,189
| – | – | 0.01% | 242 |
|
|
2013
Q2 | $198K | Buy |
+9,189
| New | +$198K | 0.01% | 244 |
|
Other funds holding VIVO
MF
NAM
Bartlett & Co's VIVO Position: Q4 2022 in Review
Bartlett & Co sold out of Meridian Bioscience Inc (VIVO) in Q4 2022, closing a stake of 2,863 shares — an estimated $90K sold.
Bartlett & Co first reported a position in VIVO in Q2 2013 and held it in 36 quarters. The position peaked at $232K in Q4 2013. 218 funds tracked by Wall St. Rank hold VIVO as of Q4 2022.
- Bartlett & Co reported no remaining Meridian Bioscience Inc position as of Q4 2022 after selling out during the quarter.
- Bartlett & Co sold 2,863 Meridian Bioscience Inc shares in Q4 2022, an estimated $90K.
- Bartlett & Co first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 36 quarters.
- Bartlett & Co's Meridian Bioscience Inc position peaked at $232K in Q4 2013.
- 218 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2022.
Based on Bartlett & Co's 13F filing for Q4 2022, filed 4 Jan 2023.